The cyclic dinucleotide c-di-GMP is a signaling molecule with diverse functions in cellular physiology. Here, we report that c-di-GMP can assemble into a tetramer that mediates the effective dimerization of a transcription factor, BldD, which controls the progression of multicellular differentiation in sporulating actinomycete bacteria. BldD represses expression of sporulation genes during vegetative growth in a manner that depends on c-di-GMP-mediated dimerization. Structural and biochemical analyses show that tetrameric c-di-GMP links two subunits of BldD through their C-terminal domains, which are otherwise separated by $10 Å and thus cannot effect dimerization directly. Binding of the c-di-GMP tetramer by BldD is selective and requires a bipartite RXD-X 8 -RXXD signature. The findings indicate a unique mechanism of protein dimerization and the ability of nucleotide signaling molecules to assume alternative oligomeric states to effect different functions.
INTRODUCTION
In all domains of life, nucleotide-based second messengers allow a rapid integration of external and internal signals into fine-tuned regulatory pathways that control cellular responses to changing conditions. As a unifying theme, a basic second messenger control module consists of two distinct enzymes for synthesis and degradation of the second messenger and a nucleotide sensor that, upon ligand binding, interacts with a target to produce a cellular output (Hengge, 2009 ). 3 0 , 5 0 -cyclic diguanylic acid (c-di-GMP), which is not produced in archaea or eukaryotes, was first discovered as an allosteric effector of cellulose synthase in Gluconacetobacter xylinus and is now recognized as one of the most important and widespread second messengers in bacteria. c-di-GMP is synthesized from two molecules of GTP by diguanylate cyclases (DGCs), which are characterized by active site GGDEF motifs (A-site) Chan et al., 2004) . The majority of active DGCs also carry a so-called inhibitory or I-site motif, RxxD, which is involved in feedback inhibition (Christen et al., 2006; Schirmer and Jenal, 2009) . Specific phosphodiesterases (PDEs), which harbor EAL or HD-GYP domains, degrade the cyclic dinucleotide (Schmidt et al., 2005; Christen et al., 2005; Ryan et al., 2006) . The enzymatically active domains involved in c-di-GMP turnover are often associated with diverse sensory domains, thus enabling cells to adjust second messenger levels in response to different environmental stimuli (Hengge, 2009) .
The binding of c-di-GMP to effector proteins impacts diverse processes such as adhesion, virulence, motility, and biofilm formation in unicellular, flagellated bacteria (Rö mling et al., 2013) . The known c-di-GMP-binding motifs of these proteins are limited but include degenerate GGDEF domain proteins carrying I-site motifs (Duerig et al., 2009; Lee et al., 2007b; Petters et al., 2012) , inactive EAL domain receptors (Navarro et al., 2009; Qi et al., 2011; Newell et al., 2009) , and PilZ domain-containing proteins (Amikam and Galperin, 2006) . Transcription factors that sense c-di-GMP lack these common c-di-GMP-binding motifs and thus must be identified experimentally. The sparse list of known c-di-GMP-responsive transcriptional regulators includes the TetR-like activator LtmA from Mycobacterium smegmatis (Li and He, 2012) , the CRP-FNR-like transcription factor Clp from Xanthomonas (Chin et al., 2010; Leduc and Roberts, 2009 ), Bcam1349 from Burkholderia (Fazli et al., 2011) , the NtrC-type protein FleQ from Pseudomonas aeruginosa (Baraquet and Harwood, 2013) , and VpsR from Vibrio cholerae (Srivastava et al., 2011) . The only c-di-GMP-responsive transcription factor for which structural information is available and hence c-di-GMP binding is understood is VpsT, which is a member of the well-studied FixJ-LuxR-CsgD family of response regulators. The VpsT structure revealed a characteristic response regulator fold and a W(F/L/M)(T/S)R c-di-GMP-binding motif (Krasteva et al., 2010) . Notably, in all known structures of c-di-GMP-binding effector proteins or enzymes, the c-di-GMP is bound either as a monomer or intercalated dimer. Biophysical studies suggest the possibility of higher order oligomeric forms of c-di-GMP, but they have yet to be observed in any biological context (Gentner et al., 2012) .
While the roles played by c-di-GMP in controlling cellular processes in unicellular bacteria are becoming clear, the function(s) of c-di-GMP in multicellular, nonmotile bacteria such as Streptomyces are unknown. The complex Streptomyces life cycle involves two distinct filamentous cell forms: the growing or vegetative hyphae and the reproductive or aerial hyphae, which differentiate into exospores for dispersion through a massive synchronous septation event (Flä rdh and Buttner, 2009 ). In the model species Streptomyces venezuelae, there are three GGDEF proteins, two proteins with HD-GYP domains, and five proteins containing both a GGDEF and an EAL domain ( Figure 1A ). Altered expression of the GGDEF proteins, CdgA and CdgB, and deletions of the EAL proteins, RmdA and RmdB, have a significant impact on Streptomyces growth progression, suggesting that c-di-GMP plays a role in controlling developmental processes in multicellular bacteria (den Hengst et al., 2010; Tran et al., 2011; Hull et al., 2012) . Interestingly, cdgA and cdgB have recently been identified as direct regulatory targets of the developmental master regulator BldD (den Hengst et al., 2010; Tran et al., 2011) . Mutations in the bld loci block the formation of aerial hyphae, resulting in a ''bald'' phenotype, and also affect the production of antibiotics (McCormick and Flä rdh, 2012) .
BldD sits at the top of the regulatory cascade controlling development, serving to repress expression of sporulation genes during vegetative growth (den Hengst et al., 2010) . In Streptomyces coelicolor, BldD controls the expression of at least 167 genes, including 42 genes ($25% of the regulon) that encode regulatory proteins (Elliot et al., 2001; den Hengst et al., 2010) . Among these BldD targets are many genes known to play critical roles in Streptomyces development, including other bld regulators (e.g., bldA, bldC, bldH/adpA, bldM, and bldN) , several whi (white) regulators required for the differentiation of aerial hyphae into spores (e.g., whiG and whiB), and genes encoding critical components of the cell division and chromosome segregation machineries such as FtsZ, SsgA, SsgB, and the DNA translocase SffA (den Hengst et al., 2010; McCormick, 2009) . How BldD activity is regulated, however, has been unknown. Figure 1 . c-di-GMP Levels Affect S. venezuelae Development (A) Domain organization of predicted active c-di-GMP-metabolizing proteins in S. venezuelae. GGDEF domains are shown as red boxes. Amino acids different from the conserved product inhibition site (RxxD) are shown in red. Noncanonical residues of the EAL domains (blue box) and HD-GYP domains (green box) are highlighted in red. Predicted transmembrane helices are shown as black bars, and N-terminal GAF, PAS, and PAC signaling domains are boxed in black. (B) Overexpression of CdgB (a DGC from S. coelicolor) or YhjH (a PDE from E. coli) from the ermEp* promoter in S. venezuelae results in loss of aerial mycelium formation. (C) SEMs reveal that while CdgB overexpression blocks development (giving rise to a classic ''bald'' phenotype; middle), YhjH overexpression (right) induces precocious hypersporulation without formation of aerial hyphae. Spore-bearing aerial hyphae of the WT are shown for comparison (left). Cells were grown on maltose-yeast extract-malt extract (MYM) agar for four days at 30 C prior to imaging.
See also Figure S1 .
Here we show that BldD is a c-di-GMP-binding effector protein, thus revealing a link between c-di-GMP signaling and the development of multicellular bacteria. Specifically, structural and biochemical analyses show that the second messenger c-di-GMP activates BldD DNA binding by driving a unique form of dimerization that is mediated by a tetrameric form of c-di-GMP. The c-di-GMP tetramer performs its oligomerization function by adjoining two BldD C-terminal domain (CTD) protomers, the polypeptide chains of which are separated by $10 Å . BldD recognizes the c-di-GMP tetramer using a bipartite RXD-X 8 -RXXD c-di-GMP interaction signature sequence from each subunit. Thus, tetrameric c-di-GMP acts as a small-molecule dimerizing agent that controls the DNA-binding activity of BldD, leading to repression of the BldD regulon of sporulation genes during vegetative growth, thereby controlling the hyphato-spore transition in multicellular bacteria.
RESULTS

c-di-GMP Controls Developmental Program Progression in Streptomyces venezuelae
To gain insight into the cellular processes controlled by c-di-GMP in streptomycetes, we overexpressed either the active DGC CdgB from S. coelicolor (Tran et al., 2011) or the active PDE YhjH from E. coli (Pesavento et al., 2008) . Strikingly, overexpression of both CdgB and YhjH blocked the generation of aerial mycelium by S. venezuelae ( Figure 1B) . However, scanning electron micrographs (SEMs) revealed that, whereas overexpression of CdgB blocked development, resulting in a classical bald phenotype, overexpression of the PDE YhjH in fact promoted sporulation, but the colonies appeared bald to the naked eye because aerial mycelium formation had been bypassed (Figure 1C) . As judged by heat resistance, the spores made by the YhjH overexpression strain were as robust as those of the wildtype (WT) (Figure S1A available online). Moreover, overexpression of catalytically inactive versions of YhjH or CdgB had no effect on S. venezuelae development ( Figure S1B ). These data suggest that intracellular levels of c-di-GMP influence the timing of development. In particular, they suggest that increased c-di-GMP levels delay differentiation, arresting the colonies in the vegetative growth stage, whereas decreased levels of the second messenger accelerate development, favoring sporulation.
BldD Is a c-di-GMP Effector Protein S. venezuelae has no PilZ domain-containing proteins, and no putative c-di-GMP-binding effector proteins have so far been identified in the Streptomyces genus. Thus, to address the mechanism by which S. venezuelae senses c-di-GMP to control sporulation, we sought to identify c-di-GMP effector proteins involved in development. To selectively enrich putative c-di-GMP-binding proteins from S. venezuelae cell extracts, we performed an affinity pull-down assay using a c-di-GMP capture compound . Captured proteins were identified by tryptic mass spectrometry fingerprinting.
Remarkably, the developmental master regulator BldD was repeatedly recovered in our c-di-GMP-based capture compound experiments. BldD is an 18 kDa DNA-binding protein (Elliot and Leskiw, 1999) consisting of two distinct domains connected by a flexible linker (Figure 2A ). The N-terminal domain is the DNA-binding domain (DBD) and has a xenobiotic response element (XRE) helix-turn-helix (HTH) DNA-binding motif . The BldD CTD harbors a largely helical fold with no known function (Kim et al., 2014) . To probe the interaction between BldD and c-di-GMP further and to identify the c-di-GMP-binding domain, we used differential radial capillary action of ligand assays (DRaCALA) (Roelofs et al., 2011) . DRaCALA allows the visualization of protein-bound radiolabeled ligand as a concentrated spot after the application of the protein-ligand mixture onto nitrocellulose. Using this assay, we confirmed that full-length (FL) BldD (expressed as an N-terminally His 6 -tagged protein) from both S. venezuelae (Figures 2B and S2B) and S. coelicolor (data not shown) bind 32 P-labeled c-di-GMP. Importantly, the DRaCALA assays demonstrated that the previously uncharacterized CTD of BldD functions as the c-di-GMPbinding domain ( Figure 2B ). Further, excess unlabeled c-di-GMP, but not GTP, competed with the labeled c-di-GMP for binding to FL BldD and to BldD-CTD. Thus, these data reveal that the CTD of the key developmental regulator BldD is a c-di-GMP-binding domain.
Cyclic di-GMP Enhances Binding of BldD to Its Target Promoters In Vitro and In Vivo
Using global chromatin immunoprecipitation-microarray analysis (ChIP-chip), we previously identified the complete BldD regulon in S. coelicolor, showing that it encompasses $167 transcription units (den Hengst et al., 2010) . Through MEME-based sequence analysis of all the promoter regions directly targeted by BldD, we defined a 13 bp pseudo-palindromic sequence, 5 0 -TNAC(N) 5 GTNA-3 0 , designated the BldD box, which functions as a specific binding sequence for BldD (den Hengst et al., 2010) . Sequence analysis showed that the BldD box was conserved between S. coelicolor and S. venezuelae for most key BldD target promoters (den Hengst et al., 2010) . Further, BldD from S. coelicolor and S. venezuelae contain an identical DBD and differ by only two residues in the DBD-CTD linker and five residues in the CTD, suggesting that BldD function is broadly conserved between the two species.
Having shown that BldD binds c-di-GMP, we tested the effect of c-di-GMP on BldD DNA binding. Radiolabeled S. venezuelae DNA fragments encompassing the promoter regions of two well-characterized BldD target genes, bldM and whiG, including the bioinformatically identified BldD box ( Figure 2C ), were used as target DNAs in electrophoretic mobility shift assays (EMSAs) ( Figure 2D ). The fixed concentration of BldD used in these assays (0.6 mM) was insufficient to elicit a DNA mobility shift. However, the addition of increasing concentrations of c-di-GMP (0.25-1.75 mM) strongly induced BldD binding to both the tested promoter regions ( Figure 2D ). To confirm and extend these results into cells, we manipulated the levels of c-di-GMP in S. venezuelae and monitored the effect on BldD binding to the bldM and whiG promoters in vivo using ChIP-sequencing (ChIP-seq). The degree of BldD binding was assayed at a single time point in WT S. venezuelae and the WT overexpressing either the DGC CdgB or the PDE YhjH (the strains whose phenotypes are described above). Consistent with the in vitro EMSA data, overexpression of the DGC enhanced ChIP-seq peak height at the BldD target promoters relative to the WT control ( Figure 2E ). Conversely, overexpression of the PDE lowered ChIP-seq peak heights at BldD target promoters relative to the WT ( Figure 2E ). These data demonstrate that c-di-GMP enhances the binding of BldD to the BldD box, stimulating BldD-mediated repression of its target regulon. Thus, it is not BldD, but a BldD-(c-di-GMP) complex, that serves to turn off sporulation genes during vegetative growth.
S. venezuelae bldD Mutants Show an Accelerated Sporulation Phenotype that Bypasses Aerial Mycelium Formation
The opposing effects of the overexpression of the DGC CdgB and the PDE YhjH suggested that high levels of c-di-GMP retard sporulation and low levels of c-di-GMP accelerate sporulation. Because the BldD-(c-di-GMP) complex serves to keep sporulation genes shut off during vegetative growth, loss of BldD should have a similar effect on Streptomyces development as depletion of c-di-GMP levels. To test this hypothesis, we deleted bldD from the S. venezuelae chromosome. Strikingly, the bldD null mutant formed small colonies lacking aerial hyphae, but-when examined by SEM-even young colonies of the bldD mutant were found to contain spore chains embedded in an excess of extracellular matrix ( Figure 3A ). Heat resistance tests showed the bldD mutant spores were mildly defective ( Figure S1A ). By contrast, equivalent young colonies of the WT that were grown and imaged in parallel had not yet developed aerial hyphae or spores (Figure 3B) . Thus, loss of BldD mimics the effects of overexpressing the PDE YhjH (compare Figures 1C and 3A ). In addition, overexpression of CdgB had no effect on the phenotype of the bldD mutant ( Figure S2A ), further supporting the idea that c-di-GMP signals through BldD to control the hypha-to-spore transition. Tables S1 and S2 ). The BldD CTD structures are composed of two (b-a-a) repeats followed by a short C-terminal helix and are similar to the apo form studied by NMR (Kim et al., 2014) (Figure 4 ). Database searches revealed that the BldD CTD harbors a new fold, but reduced stringency revealed that it shows limited structural similarity with winged HTH proteins, in particular, the winged HTH domain of eukaryotic heat shock factor 1 (HSF1) (Littlefield and Nelson, 1999) . The BldD CTD and HSF1 bind c-di-GMP and DNA, respectively, but the motifs they employ to interact with their nucleotide ligands are completely different ( Figure S3 ). The BldD CTD uses a previously unseen mode of c-di-GMP binding in which two noninteracting CTDs are glued together by a c-di-GMP tetramer composed of two interlocked c-di-GMP dimers ( Figure 4A ). Thus, in the BldD CTD-(c-di-GMP) complex, c-di-GMP functions as a macromolecular dimerizer. Indeed, the closest approach of any Ca atoms of the two tethered CTDs is $10 Å .
The BldD CTD interacts with c-di-GMP using two contiguous surface motifs, herein called motif 1 and motif 2, which are located between the two b-a-a repeats. Motif 1 is composed of residues 114-116 (RGD) and motif 2 is composed of residues 125-128 (RQDD) ( Figure 5A ). These motifs are located on a solvent exposed region at one end of each CTD protomer and not within a pocket or cavity ( Figures 4A and 5A ). The combined motifs from two CTD subunits provide ideal shape and electrostatic complementarity for encasing the unusual cage-like c-di-GMP tetramer ( Figures 4A and 4B) . Strikingly, although the BldD CTD is overall acidic (pI$5.0), the c-di-GMP-binding surface between two BldD protomers is electropositive ( Figure 4B ). In addition to shape and charge complementary, contacts from the arginine and aspartic acid residues within motifs 1 and 2 provide specificity for recognition of guanine cyclic nucleotides; the multiple interactions effectively exclude binding to adenine cyclic nucleotides. Specifically, motif 2 from each CTD protomer combine to mediate contacts to one intercalated c-di-GMP dimer, Asp116 of motif 1 from each protomer combine to mediate contacts to the other c-di-GMP dimer, while Arg114 sits centrally and anchors both dimers ( Figures 5A and 5B) . The guanine bases wedged between the two motif 2 regions are specified by contacts from residues Arg125 and Asp128 (Figures 5A and 5B). Residue Asp128 makes two hydrogen bonds to the N1 and the exocyclic N2 atoms of the guanine bases on each end (top and bottom layers) of the intercalated dimer, while Arg125 flanks the guanines in the center (middle layers) of the dimer and makes hydrogen bonds to the guanine O6 and N7 atoms ( Figures 5B-5D ). The O6 moiety is also specified by the backbone nitrogen of Arg125. Notably, the stacking interactions between the Arg125 side chains are the only direct contacts between the two CTD protomers but are clearly not sufficient to promote BldD dimerization.
Arg114 is the only CTD residue that makes contacts to both intercalated c-di-GMP dimers. Arg114 hydrogen bonds to the guanines contacted by Asp128, as well as the O6 atoms of the adjacent guanines of the other c-di-GMP dimer ( Figures 5A and 5B). Thus, Arg114 plays a key role in the recognition and stabilization of this unique c-di-GMP tetramer. The c-di-GMP dimer bound between the motif 1 regions has fewer contacts and is more exposed (Figure 5A ). In addition to contacts from Arg114, Asp116 of motif 1 hydrogen bonds to the guanine N1 and N2 atoms in a manner analogous to the contacts from Asp128 of motif 2 ( Figure 5) . Notably, the specific hydrogen bonds from motif 1 and 2 residues to guanine exocyclic O6 and N2 atoms dictate that BldD binds to c-di-GMP but not to c-di-AMP, which is missing an exocyclic atom at the 2 position and harbors a hydrogen bond donor rather than an acceptor at the exocyclic 6 position. BldD motifs 1 (RXD) and 2 (RXXD), although similar in sequence to the inhibitory I-site (RXXD), which is involved in product inhibition feedback control of DGC activity (Christen et al., 2006) , are structurally different. Further, mutagenesis of either BldD motif 1 or motif 2 abolishes c-di-GMP binding in DRaCALA assays (Figure S2B ), confirming that, unlike I-site c-di-GMP binding, both motifs 1 and 2 in BldD are required to construct the complete binding site for the tetrameric c-di-GMP complex. This dual signature sequence is unlike any previously characterized c-di-GMP-binding motif. Moreover, specific binding of the c-di-GMP tetramer requires encasement by two such bipartite motifs from precisely oriented BldD protomers. While the arginine and aspartic acid residues in BldD motifs 1 and 2 dictate the c-di-GMP-binding arrangement and read the guanine bases, contacts to the c-di-GMP phosphate groups are provided by Lys84 from b1 and Arg130 from a3. Further, Ile110 makes van der Waals interactions and residues Asn118 See also Figure S2A .
and Ser123 hydrogen bond with the guanine bases on the top and bottom layers of the c-di-GMP tetramer ( Figure 5A ). The combination of the optimally positioned bipartite signature sequences from two BldD protomers exquisitely templates binding of the specific and unusual c-di-GMP tetramer structure.
The BldD-(c-di-GMP) Structure Reveals a Tetrameric Form of the c-di-GMP Second Messenger c-di-GMP is monomeric in solution at physiological concentrations (Gentner et al., 2012) . However, intercalated c-di-GMP dimers have been observed in crystal structures of the nucleotide alone and in complexes with effector proteins. Higher order c-di-GMP structures such as tetramers and octamers have thus far only been inferred from NMR and spectroscopic studies and require very high c-di-GMP concentrations (up to 30 mM) and monovalent cations . These higher order structures are characterized by G-quartet interactions with a centrally bound potassium ion coordinated by four guanines. There are minimal base contacts and no base stacking interactions in these structures ( Figure S4A ) Gentner et al., 2012) . By sharp contrast, the BldD-bound tetrameric c-di-GMP is a tightly packed structure that is not secured by ions. Rather, the c-di-GMP molecules are closely spaced and optimally positioned for interbase pairing, leading to the formation of a multistranded, base-stacked structure with top, middle, and bottom layers ( Figures 5D and S4A ). There are 12 hydrogen bonds between the two intercalated dimers within the c-di-GMP tetramer, including contacts between the N3 atoms and exocyclic NH 2 amides of an adjacent base ( Figures 5C and S4B ). Such contacts could not be formed with c-di-AMP due to its lack of an exocyclic NH 2 atom. Therefore, in addition to contacts from motifs 1 and 2, guanine-guanine base hydrogen bonds serve to specify c-di-GMP tetramer binding to BldD. Notably, formation of the c-di-GMP tetramer buries 24% of the total surface area (buried surface area [BSA]) of the c-di-GMP molecules ( Figure  S4B ). By comparison, in most protein oligomers the BSA between protomers is $15% ). Finally, the interface between the intercalated c-di-GMP dimers that forms the tetramer is remarkably complementary in shape ( Figure S4B) . Thus, the combination of multiple contacts between the c-di-GMP moieties along with its extensive BSA and molecular shape complementarity lead to the creation of a compact and highly specific c-di-GMP tetramer. However, BldD is necessary to stabilize this tetramer and template its formation.
c-di-GMP Induces Dimerization of the BldD CTD in Solution
The BldD CTD-(c-di-GMP) crystal structures reveal that c-di-GMP acts as a ''dimerizer'' to link two CTD protomers. To examine the effect of c-di-GMP on the oligomeric state of the BldD CTD in solution, we carried out chemical crosslinking and size exclusion chromatography (SEC) studies. Chemical Tables S1 and S2. crosslinking experiments were performed using disuccinimidyl suberate (DSS), which contains amine-reactive N-hydroxysuccinimide esters at both ends of an 11 Å spacer arm. This reagent should therefore be able to crosslink even the distantly anchored CTD protomers observed in our CTD-(c-di-GMP) structures ( Figure 4A ). In the absence of DSS, the BldD DBD and CTD migrate on SDS-PAGE gels as single bands with the expected monomeric molecular weights of 11 and 12 kDa, respectively ( Figure 6A ). Upon incubation with DSS, the BldD DBD forms a covalent dimer of $21 kDa, consistent with previous biochemical and structural analyses of this domain Lee et al., 2007a) , and oligomerization is unaffected by the addition of c-di-GMP ( Figure 6A ). By contrast, the BldD CTD remains monomeric after DSS addition. However, in the presence of c-di-GMP, addition of DSS results in the clear formation of covalent CTD dimers ( Figure 6A ). To examine c-di-GMP-induced CTD oligomerization further, we performed SEC analyses. As part of this study, we mutagenized the RGD (motif 1)-X 8 -RQDD (motif 2) c-di-GMP-binding signature of the BldD CTD. To retain the charge of these surface residues, we made the charge-swapped DGR-X 8 -DQDR CTD mutant, changing the key Arg residues within the two motifs to Asp, and vice versa. DRaCALA assays showed that this mutant CTD was unable to bind c-di-GMP ( Figure S2B ). SEC experiments in the presence of 3 mM c-di-GMP showed that the WT CTD forms a dimer, while the mutant CTD is monomeric (Figure 6B) . Hence, the crosslinking and SEC data support our structural finding that c-di-GMP is required for BldD CTD dimerization. Further, we constructed a bldD mutant allele encoding a protein solely defective in c-di-GMP binding (carrying the DGR-X 8 -DQDR mutation) and found that it had no ability to complement a bldD mutant ( Figure S2A ), confirming that the major in vivo functions of BldD are indeed mediated by its binding to c-di-GMP.
. Structures of BldD CTD-(c-di-GMP) Complexes Reveal a Unique c-di-GMP Oligomer and c-di-GMP-Mediated Dimerization Mechanism
Affinity, Stoichiometry, and Specificity of c-di-GMP for BldD CTD Our structures reveal a unique interaction between the BldD CTD and a c-di-GMP tetramer. Remarkably, every guanine in this Tables S1 and S2. complex is read specifically by either BldD arginines, aspartic acids, and/or other guanine bases, suggesting that BldD binds only c-di-GMP, and not other cyclic nucleotides. To test this hypothesis and further probe the c-di-GMP-binding affinity of BldD, we performed fluorescence polarization (FP) experiments. These studies were performed with BldD CTD that was expressed and purified from Sf9 insect cells to ensure no c-di-GMP was present, as eukaryotes do not produce c-di-GMP (Extended Experimental Procedures). The BldD-(c-di-GMP) structures show that one ribose of each c-di-GMP bound to BldD must be unmodified to permit formation of the BldD-(c-di-GMP) complex ( Figure S5A ). Hence, for these studies we used the fluoresceinated probe, 2 0 -Fluo-AHC-c-di-GMP, which harbors the fluorescein dye on only one ribose ( Figure S5A ). These studies revealed BldD CTD bound to 2 0 -Fluo-AHC-c-di-GMP, with an apparent K d of 2.5 mM ± 0.6 ( Figure S5B ). Consistent with our DRaCALA assays ( Figure S2B ), the DGR-X 8 -DQDR CTD mutant failed to bind 2 0 -Fluo-AHC-c-di-GMP in FP assays ( Figure S5B ). WT BldD CTD showed no binding to the identically fluoresceinated c-di-AMP tagged molecule, 2 0 -Fluo-AHC-c-di-AMP ( Figure S5B) .
Next, to ascertain the stoichiometry of c-di-GMP binding in solution, we used an FP-based binding assay. The resulting data ( Figure S5C) show a linear increase in fluorescence polarization until saturation of the binding sites. A single inflection point can be fitted at a BldD monomer concentration of $12 mM, which equates to a stoichiometry of four c-di-GMP molecules per CTD dimer. However, careful inspection of the data reveals another potential inflection point at a BldD monomer concentration of 6 mM, which would be consistent with an initial binding event of two c-di-GMP molecules per CTD dimer. This putative initial binding event is also apparent in the equilibrium-binding isotherm yielding an apparent K d of $1.7 mM ( Figure S5B ). Two-step binding is not inconsistent with the structure, but the nearly identical affinities observed for each binding event suggest positive cooperativity. Overall, these data demonstrate unequivocally that c-di-GMP binds the CTD with a stoichiometry of four c-di-GMP molecules per CTD dimer, concordant with our structures. These studies also demonstrate that the BldD CTD binds specifically and with high affinity to c-di-GMP but not c-di-AMP and that both motifs 1 and 2 are essential for this interaction.
The Mechanism for (c-di-GMP)-Activated DNA Binding by BldD Dimeric BldD binds pseudo-palindromic DNA sites that contain a 5 0 -TNAC(N) 5 GTNA-3 0 consensus (den Hengst et al., 2010) . Our data and those of others (Lee et al., 2007a) show that the BldD DBD alone can dimerize at higher concentrations (R10 mM). Consistent with these findings, the crystal structure of the S. coelicolor BldD DBD revealed a dimer with a small contact interface . We obtained additional views of the BldD DBD by solving the S. venezuelae BldD DBD structure to 2.80 Å resolution. This structure contained two DBD dimers in the asymmetric unit. Comparison of these dimers with the dimer from the S. coelicolor DBD structure showed that, although hydrophobic residues within the C-terminal regions of the DBDs make contacts between the subunits in each case, all three dimers take distinct conformations ( Figure S6A ). Moreover, there is less than 300 Å 2 BSA per subunit in this dimer, which is far less than the 1000 Å 2 BSA per subunit typically observed for biologically relevant dimers (Krissinel and Henrick, 2007) . These data indicate that the BldD DBD is unlikely to form a stable DNA-binding active dimer at physiologically relevant concentrations. In addition, although the BldD DBD resembles the equivalent DBD of l repressor, previous modeling studies suggested that the BldD DBDs would not interact specifically with DNA if BldD employed a DNA-binding mechanism similar to that utilized by l repressor . Thus, it has been unclear how BldD binds cognate DNA. Our finding that c-di-GMP binding leads to the formation of a c-di-GMP bridged CTD dimer provides the missing link to this puzzle. However, how c-di-GMP binding to the CTDs is signaled to the DBDs to bring about DNA binding remained unclear. (B) SEC analysis of the WT BldD CTD and BldD CTD DGR-X 8 -DQDR mutant in the presence of 3 mM c-di-GMP. The WT CTD + c-di-GMP is dimeric, while the quadruple mutant is monomeric. The standard curve was determined using cytochrome C (12 kDa), carbonic anhydrase (29 kDa), and albumin (66 kDa) (green circles).
To deduce the mechanism by which c-di-GMP activates BldD to bind DNA, we determined the structure of a BldD-(c-di-GMP)-21-mer DNA complex to 4.5 Å resolution (Extended Experimental Procedures; Figure S6B ). While the low resolution of the structure precludes a detailed analysis, the electron density maps show the overall arrangement of the domains and how the DBDs dock onto the DNA. Critically, the structure reveals that BldD binding to cognate DNA is more similar to the DNA binding mode of the XRE protein SinR (Lewis et al., 1998; Newman et al., 2013) than to that of the l repressor, as the two BldD DBDs are juxtaposed when BldD is bound to DNA (Figures 7A and 7B) . The DBD-DBD interacting surfaces observed in the BldD-DNA complex correspond to the hydrophobic regions near the DBD C terminus that interact in the apo DBD structures. However, the interfaces are yet again different, supporting the notion that DBD dimerization is weak and malleable. Such malleability is critical to allow the dimeric BldD HTH elements to bind the DNA, which is bent by $30 . The BldD DBDs are tethered to the CTD via a linker that was previously shown to be highly flexible Lee et al., 2007a) . Not surprisingly, this linker (PGTTPGGAAEPPP; residues 71-84) is disordered in the BldD-(c-di-GMP)-21-mer structure. Its flexibility is underscored by the different orientation of the two CTDs in the structure relative to the DBD-DNA complex ( Figure 7A ). The CTD subunits in the dimer make different interactions that help anchor them in the BldD-(c-di-GMP)-DNA crystal; one of the CTDs interacts with a hydrophobic patch on its cognate DBD, while the other CTD makes crystal contacts with a symmetry mate ( Figures 7A and S6C) . However, the CTDs in the FL BldD-(c-di-GMP)-DNA structure are dimerized in a manner identical to that observed in our CTD-(c-di-GMP) structures ( Figures 4D, 5A , 7A, and S6C).
Additional evidence that the linker region between the DBD and CTD is flexible was provided by proteolysis experiments employing Endoproteinase Glu-C, which cleaves exposed peptide bonds on the carboxyl side of glutamic or aspartic acid residues. Hence, if the BldD linker region is unstructured, Glu-C should selectively cleave after BldD residue Glu80. Glu-C proteolysis experiments were carried out on the FL BldD protein, the FL protein with the 21-mer DNA present, and the FL protein in the presence of both c-di-GMP and the 21-mer DNA. In all three cases BldD was readily cleaved into two bands, corresponding to the DBD and the CTD ( Figure S6D ). Thus, neither the presence of DNA, nor of c-di-GMP and DNA, protected BldD from proteolysis, indicating the linker is exposed even in the presence of cognate ligands. Therefore, the combined data suggest a molecular model for c-di-GMP activation of BldD DNA binding in which binding of c-di-GMP leads to the formation of a c-di-GMP-linked BldD CTD dimer ( Figure 7C ). Such CTD dimerization effectively brings the two DBDs into proximity, thereby increasing their local concentration to allow germane DBD dimerization on cognate DNA ( Figure 7C ). The inherent flexibility afforded by the DBD-CTD linker allows the DBDs to adjust for optimal binding to multiple pseudo-palindromic BldD DNA boxes.
DISCUSSION
The role of c-di-GMP has been studied extensively in unicellular Gram-negative bacteria, in which most c-di-GMP-dependent signaling pathways control the transition from a planktonic, motile lifestyle to a surface-associated, sessile lifestyle (''stick or swim''). Here we show that the activity of the Streptomyces master regulator BldD is also controlled by c-di-GMP, thus bringing the regulatory role of this key second messenger into a new physiological arena, that of differentiation in Gram-positive multicellular bacteria. Our studies indicate that c-di-GMP binding to BldD controls the developmental switch between . Increased c-di-GMP levels lead to BldD CTD dimerization, resulting in a significant increase in the local concentration of the DBDs, allowing them to dimerize optimally in the presence of cognate DNA to effect high affinity DNA binding. This leads to repression of the BldD regulon, thus blocking multicellular differentiation. See also Figure S6 and Table S2. vegetative growth and sporulation. Specifically, we demonstrate that c-di-GMP binding to BldD activates its DNA-binding activity, which results in repression of sporulation genes during vegetative growth. Consistent with this, genetic studies revealed that bldD null mutants sporulate precociously, mimicking the effect of overexpressing a c-di-GMP phosphodiesterase. Thus, c-di-GMP signals through BldD to control the hypha-to-spore developmental transition in Streptomyces.
Few c-di-GMP effector-binding motifs have been identified to date. These include I-site motifs (Duerig et al., 2009; Lee et al., 2007b; Petters et al., 2012) , inactive EAL domains (Navarro et al., 2009; Qi et al., 2011; Newell et al., 2009) , and PilZ domains (Amikam and Galperin, 2006) . Structures have shown that c-di-GMP interacts with these motifs as either a monomer or intercalated dimer. The BldD protein does not contain any previously characterized c-di-GMP effector-binding motifs. Thus, to elucidate the mechanism by which c-di-GMP acts as a switch to turn on the DNA-binding activity of BldD, we determined several structures of the BldD CTD complexed to c-di-GMP as well as a 4.5 Å structure of the BldD-(c-di-GMP)-DNA complex. These structures revealed that BldD interacts with c-di-GMP using a heretofore unseen c-di-GMP binding mode involving a unique c-di-GMP-binding signature sequence consisting of two proximal arginine and aspartic acid containing motifs, motif 1 (RXD) and motif 2 (RXXD), separated by eight residues. Remarkably, in this binding mode, a tetrameric form of the c-di-GMP functions as a small-molecule dimerizer to adjoin two noninteracting BldD protomers. Notably, the identical CTD dimer-(c-di-GMP) tetramer structure was seen in multiple crystal forms. Finally, binding studies confirmed that the BldD CTD binds c-di-GMP with a stoichiometry of four c-di-GMP molecules to one BldD CTD dimer. The c-di-GMP tetramer revealed in these structures represents a previously unknown form of this nucleotide second messenger. Indeed, we do not know of any other example in which a signaling molecule can assume different oligomeric states to effect its function.
BldD is present throughout the sporulating actinomycetes (den Hengst et al., 2010) , including, for example, nitrogen-fixing Frankia that live in symbiosis within the root nodules of alder trees, and members of the marine genus Salinospora, which have recently emerged as an important source of antibiotics and other medically significant compounds. Outside of the genus Streptomyces, the only actinomycete in which BldD has been investigated is Saccharopolyspora erythraea, where BldD directly controls expression of the biosynthetic cluster of the clinically important antibiotic erythromycin (Chng et al., 2008) . Homologs from across the sporulating actinomycetes share 77%-99% sequence identity with S. venezuelae BldD. The main region of conservation between these proteins is the N-terminal DNA-binding domain, which shares 95%-100% identity. Although our BldD-(c-di-GMP)-DNA structure is too low resolution to ascribe specific protein-DNA contacts, it reveals the location of the HTH motif and residues that likely contact the DNA. Notably, these amino acids are the most conserved among BldD homologs (essentially 100%; Figure S7 ). By contrast, the CTD regions of BldD proteins are less well conserved (as low as 48% identity). Hence, it is striking, given this low conservation, that the residues that interact with c-di-GMP are strictly conserved ( Figure S7 ). The only exception is Lys84, which contacts c-di-GMP phosphate groups. However, in all BldD homologs this residue is either a lysine or arginine and thus able to make the same electrostatic interaction. Of particular note, residues R114, D116, R125, and D128 (from motifs 1 and 2), which mediate essential specifying contacts with c-di-GMP, are conserved in all homologs ( Figure S7 ). Further, all of the actinomycetes that encode an ortholog of BldD also encode GGDEF domain-containing DGCs. These combined findings indicate that BldD-(c-di-GMP) is likely to control key developmental processes throughout the sporulating actinomycetes, using tetrameric c-di-GMP as a second messenger.
EXPERIMENTAL PROCEDURES
For a full explanation of the experimental protocols, see Extended Experimental Procedures in Supplemental Information.
Bacterial Strains, Plasmids, and bldD Null Mutant Construction Strains and plasmids used are shown in Table S3 , and oligonucleotides used are shown in Table S4 . Plasmids were constructed as described in Extended Experimental Procedures. A bldD null mutant (SV77) was constructed by Redirect PCR targeting, and the bldD::apr mutant allele was moved into a new WT background by generalized transduction using the S. venezuelae-specific phage SV1. Transduction of the bldD::apr allele was confirmed by PCR and the strain was named SV74.
Capture of c-di-GMP-Binding Proteins and Differential Radial Capillary Action of Ligand Assays
Cyclic di-GMP capture compound experiments were performed as described previously but with the minor modifications described in Extended Experimental Procedures. Briefly, the c-di-GMP capture compound was added to the soluble lysates and, following UV irradiation in the caproBox, magnetic streptavidin beads were added to the reaction. After incubation the beads were collected, washed, and boiled in sample buffer, the proteins released were run on SDS-PA gels and cut out for mass spectrometry analysis. The DRaCALA assays used His 6 -BldD or N-terminally His-tagged domains, which were incubated with $11 nM 32 P-c-di-GMP. The competition experiments had 266 mM cold c-di-GMP or GTP added to the reaction. Samples were spotted onto nitrocellulose membranes and analyzed using Phosphorimaging.
DNA-Binding Assays: EMSA and ChIP-Seq Experiments DNA fragments spanning the bldM (158 bp) and whiG (151 bp) promoter regions of S. venezuelae were generated by PCR and 5 0 end labeled using [g 32 -P]-ATP and T4 polynucleotide kinase. The binding reactions were performed using 0.6 mM His 6 -BldD and radiolabeled DNA ($8,000 cpm) as well as 0.5 mg poly[d(I-C)] as nonspecific competitor DNA. When appropriate, increasing amounts of c-di-GMP (0.25-1.75 mM) were added to the mixture. The reaction samples were incubated for 20 min at room temperature and then run on 5% polyacrylamide gels. Chromatin immunoprecipitations were performed as described (Bush et al., 2013) using an anti-BldD polyclonal antibody.
Biochemical Studies on BldD Oligomeric State
The oligomeric states of BldD and its domains were analyzed via chemical crosslinking using DSS in the presence and absence of c-di-GMP (see the Extended Experimental Procedures) and visualized on SDS-PA gels. Molecular weight analyses using SEC experiments were performed with a HiLoad 16/ 600 Superdex 75 pg column.
Crystallization and Structures Determination of BldD Complexes
For detailed descriptions of the protein expression, purification, crystallization, structure determination, and refinement protocols, see the Extended Experimental Procedures.
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The Protein Data Bank (PDB) accession numbers for the crystallographic work reported in this paper are 4OAX, 4OAY, 4OAZ, and 4OB4, and the ArrayExpress accession number for the ChIP-seq data is E-MTAB-2196. 
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